The Metacognitive therapy institute (MCT-I) is an international mental health company founded by leading experts in the field of metacognitive therapy (MCT) and cognitive therapy (CBT). The company’s director and head office is based in Manchester, UK.The other branch is established in Trondheim, Norway.
The main purpose of the company is to develop and disseminate effective psychological treatments to people suffering from psychological disorders. We also develop and provide resources for mental health workers and therapists and offer training workshops to develop high competency skills as protocol therapists in MCT and CBT. We aim to develop a network of MCT-I certified clinicians who are competent MCT practitioners and able to deliver effective treatment to patients with anxiety disorders, trauma, depression and personality disorders. MCT is a regulated therapy and should only be delivered by an MCT-I registered therapists. See our registered therapists page to find an MCT-I registered therapist near you.
The MCT-institute works in accordance with the guidelines and ethical codes of the health authorities in the UK and EU in research and treatment. Only cognitive oriented treatments that are evidence-based for the various mental health disorders are supervised and disseminated.
by Adrian Wells
Attention Training Technique (ATT) is a specific treatment technique developed by Wells (1990) for use in metacognitive therapy. Whilst this technique was originally developed to be a component of treatment, experimental studies have suggested that it can in some instances have significant beneficial effects on anxiety and depression when practiced in its own right. However, we recommend that ATT is used in the context of a full metacognitive therapy treatment package for optimal effects.
The most reliable and objective way of determining the nature and cause of symptoms is through a complete diagnostic assessment. The first visit should be to the family doctor. There are many medical conditions that can give rise to depression, anxiety-like or other psychological symptoms and it is important to rule-out medical or biological causes before exploring a psychological explanation. Some medical conditions require urgent specialist treatment.
Caselli et al (2018) conducted the first case series of Metacognitive Therapy for Alcohol Use Disorder (AUD). Five patients received 12 one-hour sessions of individual MCT. At post-treatment all patients demonstrated large and clinically meaningful reductions in weekly alcohol use and the number of binge
CBT is commonly recommended for treating OCD however treatment outcomes have not been benchmarked in real world settings. Benchmarking, is a clinical audit that compares outcomes of a routinely delivered clinical service to outcome in randomized controlled trials. The study had two aims: (1) benchmark
Treatment outcome in psychological therapy is often based on presence or absence of a disorder or severity of diagnostic symptoms using scores from questionnaires. However less is known about the mechanisms that treatments act on that lead to a decrease in diagnostic symptoms. Johnson &
